SCHEMBL6540252

SCHEMBL6540252

CC(C)(Cc1ccc(I)cc1)NC(=O)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
ACACB O00763 2/20 0.37
TRPV1 Q8NER1 2/20 0.36
KDM4E B2RXH2 1/20 0.36
EPHX2 P34913 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
OPRM1 P35372 2/20 0.35
OPRD1 P41143 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6330677 0.83 CYP3A4 (0.64) ALDH1A1CYP3A4CYP2C9CYP2C19OPRM1
SCHEMBL6331086 0.83 KMT2A (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL1998840 0.81 CYP3A4 (0.49) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL255803 0.81 ACACB (0.52) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL6540103 0.79 ALDH1A1 (0.41) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL6336665 0.79 GSK3B (0.47) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL6539524 0.78 MEN1 (0.47) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL6540818 0.77 MEN1 (0.46) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL255661 0.76 PTPRB (0.41) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL10187977 0.75 ACACB (0.57) ALDH1A1CYP3A4CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138462-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-07-15 US disclosed
EP-1389185-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
WO-2002094770-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138462-A1 Aminoalcohol derivatives BPHL, FANCD2, HRH2 ALDH1A1 188/4885CYP3A4 4197/4885CYP2C9 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.